Human Genome Epidemiology Literature Finder
|
Records 1 - 30 (of 83 Records) |
| Query Trace: Carcinoma and FGFR3[original query] |
|---|
| Fibroblast Growth Factor Receptor 3 Alteration Status is Associated with Differential Sensitivity to Platinum-based Chemotherapy in Locally Advanced and Metastatic Urothelial Carcinoma. European urology 2020 8 78 (6): 907-915. Teo Min Yuen, Mota Jose Mauricio, Whiting Karissa A, Li Han A, Funt Samuel A, Lee Chung-Han, Solit David B, Al-Ahmadie Hikmat, Milowsky Matthew I, Balar Arjun V, Pietzak Eugene, Dalbagni Guido, Bochner Bernard H, Ostrovnaya Irina, Bajorin Dean F, Rosenberg Jonathan E, Iyer Go |
| FGFR3 Mutation Status and FGFR3 Expression in a Large Bladder Cancer Cohort Treated by Radical Cystectomy: Implications for Anti-FGFR3 Treatment?. European urology 2020 7 78 (5): 682-687. van Rhijn Bas W G, Mertens Laura S, Mayr Roman, Bostrom Peter J, Real Francisco X, Zwarthoff Ellen C, Boormans Joost L, Abas Cheno, van Leenders Geert J L H, Götz Stefanie, Hippe Katrin, Bertz Simone, Neuzillet Yann, Sanders Joyce, Broeks Annegien, van der Heijden Michiel S, Jewett Michael A S, Marquez Mirari, Stoehr Robert, Zlotta Alexandre R, Eckstein Markus, Soorojebally Yanish, Roshani Hossain, Burger Maximilian, Otto Wolfgang, Radvanyi François, Sirab Nanor, Pouessel Damien, Wullich Bernd, van der Kwast Theo H, Malats Núria, Hartmann Arndt, Allory Yves, Zuiverloon Tahlita C |
| Analysis of FGFR3 and HRAS genes in patients with bladder cancer. Medical journal of the Islamic Republic of Iran 2020 12 34 108. Homami Ameneh, Ataei Kachoei Zohreh, Asgarie Mojgan, Ghazi Farid |
| Genomic characterization reveals potential biomarkers in nasopharyngeal carcinoma patients with relapse. Expert review of molecular diagnostics 2020 10 20 (11): 1149-1159. Cho William C S, Tse Ka-Po, Ngan Roger K C, Cheuk Wah, Ma Victor W S, Yang Yi-Ting, Yip Timothy T C, Tan Kien Thiam, Chen Shu-J |
| Fibroblast Growth Factor Receptor 3 Mutation as a Prognostic Indicator in Patients with Urothelial Carcinoma: A Systematic Review and Meta-analysis. European urology open science 2020 Oct 21 61-68. Khalid Sidra, Basulaiman Bassam Mohammed, Emack Jeffrey, Booth Christopher M, Duran Ignacio, Robinson Andrew G, Berman David, Smoragiewicz Martin, Amir Eitan, Vera-Badillo Francisco |
| Genomic profile - a possible diagnostic and prognostic marker in upper tract urothelial carcinoma. BJU international 2021 8 130 (1): 92-101. Grahn Alexandra, Eisfeldt Jesper, Malm Camilla, Foroughi Asl Hassan, Jaremko Georg, Tham Emma, Brehmer Marian |
| High Prevalence of DICER1 Mutations and Low Frequency of Gene Fusions in Pediatric Follicular-Patterned Tumors of the Thyroid. Endocrine pathology 2021 7 32 (3): 336-346. Bae Ja-Seong, Jung Seung-Hyun, Hirokawa Mitsuyoshi, Bychkov Andrey, Miyauchi Akira, Lee Sohee, Chung Yeun-Jun, Jung Chan Kw |
| Comparison of Genomic Characterization in Upper Tract Urothelial Carcinoma and Urothelial Carcinoma of the Bladder. The oncologist 2021 5 26 (8): e1395-e1405. Yang Kaiwei, Yu Wei, Liu Huanhuan, Ding Feng, Zhang Yanrui, Zhang Yun, Wang Wang, Lou Feng, Cao Shanbo, Wang Huina, He Zhiso |
| Clinicopathologic and Genomic Characterization of PD-L1 Positive Urothelial Carcinomas. The oncologist 2021 Mar . Huang Richard S P, Haberberger James, Harries Lukas, Severson Eric, Duncan Daniel L, Ferguson N Lynn, Hemmerich Amanda, Edgerly Claire, Murugesan Karthikeyan, Xiao Jinpeng, McEwan Deborah, Holmes Oliver, Hiemenz Matthew, Venstrom Jeffrey, Elvin Julia A, Creeden James, Lin Douglas I, Ross Jeffrey S, Ramkissoon Shakti |
| Fibroblast growth factor receptor: A systematic review and meta-analysis of prognostic value and therapeutic options in patients with urothelial bladder carcinoma. Urologic oncology 2021 3 39 (7): 409-421. Kardoust Parizi Mehdi, Margulis Vitaly, Lotan Yair, Mori Keiichiro, Shariat Shahrokh |
| Mismatch Repair Deficiency and Somatic Mutations in Human Sinonasal Tumors. Cancers 2021 12 13 (23): . Hieggelke Lena, Heydt Carina, Castiglione Roberta, Rehker Jan, Merkelbach-Bruse Sabine, Riobello Cristina, Llorente José Luis, Hermsen Mario A, Buettner Reinha |
| Infigratinib in Early-Line and Salvage Therapy for FGFR3-Altered Metastatic Urothelial Carcinoma. Clinical genitourinary cancer 2021 11 20 (1): 35-42. Lyou Yung, Rosenberg Jonathan E, Hoffman-Censits Jean, Quinn David I, Petrylak Daniel, Galsky Matthew, Vaishampayan Ulka, De Giorgi Ugo, Gupta Sumati, Burris Howard, Rearden Jessica, Li Ai, Xu Cindy, Andresen Corina, Moran Susan, Daneshmand Siamak, Bajorin Dean, Pal Sumanta K, Grivas Petr |
| Differences in genomic profile of high-grade urothelial carcinoma according to tumor location. Urologic oncology 2021 10 40 (3): 109.e1-109.e9. Park Cheol Keun, Cho Nam Ho |
| Natural history, response to systemic therapy, and genomic landscape of plasmacytoid urothelial carcinoma. British journal of cancer 2021 1 124 (7): 1214-1221. Teo Min Yuen, Al-Ahmadie Hikmat, Seier Kenneth, Tully Christopher, Regazzi Ashley M, Pietzak Eugene, Solit David B, Tickoo Satish, Reuter Victor, Cha Eugene K, Herr Harry, Donahue Timothy, Donat Sherri M, Dalbagni Guido, Bochner Bernard H, Funt Samuel, Iyer Gopakumar V, Bajorin Dean F, Ostrovnaya Irina, Rosenberg Jonathan |
| Therapeutic Targeting of FGFR Signaling in Head and Neck Cancer. Cancer journal (Sudbury, Mass.) 2022 9 28 (5): 354-362. Wang Zechen, Anderson Karen |
| The Role of the Key Differentially Mutated Gene FGFR3 in the Immune Microenvironment of Bladder Cancer. Journal of immunology research 2022 8 2022 7952706. Jiang Jun, Zhan Yan, Li J |
| ANXA10 Expression Is Inversely Associated with Tumor Stage, Grade, and TP53 Expression in Upper and Lower Urothelial Carcinoma. Pathobiology : journal of immunopathology, molecular and cellular biology 2022 7 1-10. Kobayashi Go, Hayashi Tetsutaro, Sentani Kazuhiro, Ikeda Kenichiro, Babasaki Takashi, Shigematsu Yoshinori, Sekino Yohei, Uraoka Naohiro, Teishima Jun, Matsubara Akio, Hinata Nobuyuki, Oue Naohi |
| Clinicopathological Features of FGFR3 - Mutated Upper Tract Urothelial Carcinoma: A Genomic Database Analysis. Clinical genitourinary cancer 2022 Jun . Rizzo Alessandro, Mollica Veronica, Santoni Matteo, Massari Frances |
| Identification of potential biomarkers and novel therapeutic targets through genomic analysis of small cell bladder carcinoma and associated clinical outcomes. Urologic oncology 2022 May . Burgess Earle F, Sanders J Alexa, Livasy Chad, Symanowski James, Gatalica Zoran, Steuerwald Nury M, Arguello David, Brouwer Cory R, Korn W Michael, Grigg Claud M, Zhu Jason, Matulay Justin T, Clark Peter E, Heath Elisabeth I, Raghavan Der |
| PD-L1 expression and FGFR-mutations among Danish patients diagnosed with metastatic urothelial carcinoma: A retrospective and descriptive study. APMIS : acta pathologica, microbiologica, et immunologica Scandinavica 2022 5 130 (8): 498-506. Grantzau Trine, Toft Birgitte Grønkaer, Melchior Linea Cecilie, Elversang Johanna, Stormoen Dag Rune, Omland Lise Høj, Pappot Hel |
| Urinary Analysis of FGFR3 and TERT Gene Mutations Enhances Performance of Cxbladder Tests and Improves Patient Risk Stratification. The Journal of urology 2022 12 209 (4): 762-772. Lotan Yair, Raman Jay D, Konety Badrinath, Daneshmand Siamak, Schroeck Florian, Shariat Shahrokh F, Black Peter, de Lange Michel, Asroff Scott, Goldfischer Evan, Efros Mitchell, Chong Kian Tai, Huang Eugene, Chua Hong Liang, Wu Qing Hui, Yeow Siying, Lau Weida, Yong Jin, Eng Mol |
| Hypoxia-Inducible Factor-2-Altered Urothelial Carcinoma: Clinical and Genomic Features. Current oncology (Toronto, Ont.) 2022 11 29 (11): 8638-8649. Vlachostergios Panagiotis J, Tamposis Ioannis A, Anagnostou Maria, Papathanassiou Maria, Mitrakas Lampros, Zachos Ioannis, Thodou Eleni, Samara Maria, Tzortzis Vassili |
| High Level of Aristolochic Acid Detected With a Unique Genomic Landscape Predicts Early UTUC Onset After Renal Transplantation in Taiwan. Frontiers in oncology 2022 1 11 828314. Lai Hong-Yue, Wu Li-Ching, Kong Po-Hsin, Tsai Hsin-Hwa, Chen Yen-Ta, Cheng Yuan-Tso, Luo Hao-Lun, Li Chien-Fe |
| Fibroblast growth factor receptor 3 mutation attenuates response to immune checkpoint blockade in metastatic urothelial carcinoma by driving immunosuppressive microenvironment. Journal for immunotherapy of cancer 2023 9 11 (9): . Yuxuan Song, Yun Peng, Caipeng Qin, Yulong Wang, Wenbo Yang, Yiqing Du, Tao |
| The genomic landscape associated with resistance to aromatase inhibitors in breast cancer. Genomics & informatics 2023 7 21 (2): e20. Kirithika Sadasivam, Jeevitha Priya Manoharan, Hema Palanisamy, Subramanian Vidyalaksh |
| Large, Nested Variant of Urothelial Carcinoma Is Enriched with Activating Mutations in Fibroblast Growth Factor Receptor-3 among Other Targetable Mutations. Cancers 2023 6 15 (12): . Yaser Gamallat, Mitra Afsharpad, Soufiane El Hallani, Christopher A Maher, Nimira Alimohamed, Eric Hyndman, Tarek A Bism |
| Different Mutational Landscape in HPV-induced and HPV-independent Invasive Penile Squamous Cell Cancers. Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc 2023 6 100250. Mikhail S Ermakov, Karl Kashofer, Sigrid Regau |
| Frequent Telomerase Reverse Transcriptase (TERT) Promoter and Fibroblast Growth Factor Receptor 3 (FGFR3) Mutations Support the Precursor Nature of Papillary Urothelial Hyperplasia of the Urinary Bladder. Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc 2023 3 100151. Cheng Liang, Lopez-Beltran Antonio, Wang Mingsheng, Whaley Rumeal D, De Souza Andre, Au Sammy, Ge Rongbin, Cimadamore Alessia, Amin Ali, Golijanin Borivoj, MacLennan Gregory T, Osunkoya Adeboye O, Montironi Rodolfo, Zhang Shao |
| A Novel Methylation Marker NRN1 plus TERT and FGFR3 Mutation Using Urine Sediment Enables the Detection of Urothelial Bladder Carcinoma. Cancers 2023 2 15 (3): . Zhang Junjie, Xu Ran, Lu Qiang, Xu Zhenzhou, Liu Jianye, Li Pei, Zhang Yaqun, Zhou Chuanchi, Luo Lufeng, Tang Wei, Wang Zhenting, Cao Manman, Cao Jian, Xu Genming, Wang Lo |
| Lung cancer presenting with central nervous system metastasis: Clinicopathological and molecular analysis of 171 cases. Annals of diagnostic pathology 2023 1 63 152082. Demleitner Madeleine, Erlenbach-Wünsch Katharina, Coras Roland, Erber Ramona, Polifka Iris, Eyüpo?lu Ilker, Fuchs Florian, Hartmann Arndt, Agaimy Abb |
- Page last reviewed:Oct 1, 2023
- Page last updated:Dec 04, 2023
- Content source: